Weighted Average Number of Shares Outstanding, Basic of Apyx Medical Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: Apyx Medical Corp quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
Apyx Medical Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 41,095,000, a 16% increase year-over-year.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 41,095,000, a 16% increase from 2024.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 35,542,000, a 2.7% increase from 2023.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 34,622,000, a 0.31% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Apyx Medical Corp Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	41,095,000	+5,553,000	+16%	01 Oct 2025	31 Dec 2025	10-K	10 Mar 2026	2025	FY
Q3 2025	40,748,000	+6,104,000	+18%	01 Jul 2025	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	40,729,000	+6,085,000	+18%	01 Apr 2025	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	40,729,000	+6,085,000	+18%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	35,542,000	+920,000	+2.7%	01 Oct 2024	31 Dec 2024	10-K	10 Mar 2026	2025	FY
Q3 2024	34,644,000	+2,000	+0.01%	01 Jul 2024	30 Sep 2024	10-Q	06 Nov 2025	2025	Q3
Q2 2024	34,644,000	+41,000	+0.12%	01 Apr 2024	30 Jun 2024	10-Q	07 Aug 2025	2025	Q2
Q1 2024	34,644,000	+46,000	+0.13%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q4 2023	34,622,000	+106,000	+0.31%	01 Oct 2023	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q3 2023	34,642,000	+73,000	+0.21%	01 Jul 2023	30 Sep 2023	10-Q	08 Nov 2024	2024	Q3
Q2 2023	34,603,000	+139,000	+0.4%	01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2024	2024	Q2
Q1 2023	34,598,000	+169,000	+0.49%	01 Jan 2023	31 Mar 2023	10-Q	09 May 2024	2024	Q1
Q4 2022	34,516,000	+184,000	+0.54%	01 Oct 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	34,569,000	+239,000	+0.7%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	34,464,000	+143,000	+0.42%	01 Apr 2022	30 Jun 2022	10-Q	11 Aug 2023	2023	Q2
Q1 2022	34,429,000	+127,000	+0.37%	01 Jan 2022	31 Mar 2022	10-Q	11 May 2023	2023	Q1
Q4 2021	34,332,000			01 Oct 2021	31 Dec 2021	10-K	16 Mar 2023	2022	FY
Q3 2021	34,330,000	+114,000	+0.33%	01 Jul 2021	30 Sep 2021	10-Q	10 Nov 2022	2022	Q3
Q2 2021	34,321,000	+135,000	+0.4%	01 Apr 2021	30 Jun 2021	10-Q	11 Aug 2022	2022	Q2
Q1 2021	34,302,000			01 Jan 2021	31 Mar 2021	10-Q	12 May 2022	2022	Q1
Q3 2020	34,216,000			01 Jul 2020	30 Sep 2020	10-Q	12 Nov 2021	2021	Q3
Q2 2020	34,186,000			01 Apr 2020	30 Jun 2020	10-Q	12 Aug 2021	2021	Q2
Q4 2018	33,185,000	+1,765,000	+5.6%	01 Oct 2018	31 Dec 2018	10-K	31 Mar 2020	2019	FY
Q3 2018	33,275,000	+2,197,000	+7.1%	01 Jul 2018	30 Sep 2018	10-Q/A	08 May 2020	2018	Q3
Q2 2018	32,890,000	+2,030,000	+6.6%	01 Apr 2018	30 Jun 2018	10-Q	01 Aug 2018	2018	Q2
Q1 2018	32,878,000	+2,018,000	+6.5%	01 Jan 2018	31 Mar 2018	10-Q	15 May 2018	2018	Q1
Q4 2017	31,420,000	+3,987,000	+15%	01 Oct 2017	31 Dec 2017	10-K	31 Mar 2020	2019	FY
Q3 2017	31,078,000	+4,003,000	+15%	01 Jul 2017	30 Sep 2017	10-Q/A	08 May 2020	2018	Q3
Q2 2017	30,860,000	+3,809,000	+14%	01 Apr 2017	30 Jun 2017	10-Q	01 Aug 2018	2018	Q2
Q1 2017	30,860,000	+3,809,000	+14%	01 Jan 2017	31 Mar 2017	10-Q	15 May 2018	2018	Q1
Q4 2016	27,433,000	+3,100,000	+13%	01 Oct 2016	31 Dec 2016	10-K	14 Mar 2019	2018	FY
Q3 2016	27,075,000	+24,000	+0.09%	01 Jul 2016	30 Sep 2016	10-Q	03 Nov 2017	2017	Q3
Q2 2016	27,051,000	+27,026,565		01 Apr 2016	30 Jun 2016	10-Q	03 Aug 2017	2017	Q2
Q1 2016	27,051,000	+8,436,000	+45%	01 Jan 2016	31 Mar 2016	10-Q	15 May 2017	2017	Q1
Q4 2015	24,333,000	+6,577,000	+37%	01 Oct 2015	31 Dec 2015	10-K	13 Mar 2018	2017	FY
Q3 2015	27,051,000	+9,271,000	+52%	01 Jul 2015	30 Sep 2015	10-Q	27 Oct 2016	2016	Q3
Q2 2015	24,435^*	-17,692,565		01 Apr 2015	30 Jun 2015	10-Q	02 Aug 2016	2016	Q2
Q1 2015	18,615,000	+18,597,316		01 Jan 2015	31 Mar 2015	10-Q	11 May 2016	2016	Q1
Q4 2014	17,756,000	-4,000	-0.02%	01 Oct 2014	31 Dec 2014	10-K	10 Mar 2017	2016	FY
Q3 2014	17,780,000	+17,762,322		01 Jul 2014	30 Sep 2014	10-Q	05 Nov 2015	2015	Q3
Q2 2014	17,717,000	+17,699,331		01 Apr 2014	30 Jun 2014	10-Q	07 Aug 2015	2015	Q2
Q1 2014	17,684^*	+34		01 Jan 2014	31 Mar 2014	10-Q	08 May 2015	2015	Q1
Q4 2013	17,760,000			01 Oct 2013	31 Dec 2013	10-K	18 Mar 2016	2015	FY
Q3 2013	17,678^*	+44		01 Jul 2013	30 Sep 2013	10-Q	10 Nov 2014	2014	Q3
Q2 2013	17,669^*	+40		01 Apr 2013	30 Jun 2013	10-Q	08 Aug 2014	2014	Q2
Q1 2013	17,650^*	-17,604,350		01 Jan 2013	31 Mar 2013	10-Q	15 May 2014	2014	Q1
Q3 2012	17,634^*	-17,583,366		01 Jul 2012	30 Sep 2012	10-Q	14 Nov 2013	2013	Q3
Q2 2012	17,629^*	-17,582,371		01 Apr 2012	30 Jun 2012	10-Q/A	25 Sep 2013	2013	Q2
Q1 2012	17,622,000	+17,604,425		01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q3 2011	17,601,000	+44,000	+0.25%	01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2012	2012	Q3
Q2 2011	17,600,000	+17,582,623		01 Apr 2011	30 Jun 2011	10-Q	14 Aug 2012	2012	Q2
Q1 2011	17,575^*			01 Jan 2011	31 Mar 2011	10-Q	15 May 2012	2012	Q1
Q3 2010	17,557,000			01 Jul 2010	30 Sep 2010	10-Q	14 Nov 2011	2011	Q3
Q2 2010	17,377^*			01 Apr 2010	30 Jun 2010	10-Q	12 Aug 2011	2011	Q2

Apyx Medical Corp Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	41,095,000	+5,553,000	+16%	01 Jan 2025	31 Dec 2025	10-K	10 Mar 2026	2025	FY
2024	35,542,000	+920,000	+2.7%	01 Jan 2024	31 Dec 2024	10-K	10 Mar 2026	2025	FY
2023	34,622,000	+106,000	+0.31%	01 Jan 2023	31 Dec 2023	10-K	13 Mar 2025	2024	FY
2022	34,516,000	+184,000	+0.54%	01 Jan 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
2021	34,332,000	+120,000	+0.35%	01 Jan 2021	31 Dec 2021	10-K	16 Mar 2023	2022	FY
2020	34,212,000	+143,000	+0.42%	01 Jan 2020	31 Dec 2020	10-K	17 Mar 2022	2021	FY
2019	34,069,000	+884,000	+2.7%	01 Jan 2019	31 Dec 2019	10-K	31 Mar 2020	2019	FY
2018	33,185,000	+1,765,000	+5.6%	01 Jan 2018	31 Dec 2018	10-K	31 Mar 2020	2019	FY
2017	31,420,000	+3,987,000	+15%	01 Jan 2017	31 Dec 2017	10-K	31 Mar 2020	2019	FY
2016	27,433,000	+3,100,000	+13%	01 Jan 2016	31 Dec 2016	10-K	14 Mar 2019	2018	FY
2015	24,333,000	+6,577,000	+37%	01 Jan 2015	31 Dec 2015	10-K	13 Mar 2018	2017	FY
2014	17,756,000	-4,000	-0.02%	01 Jan 2014	31 Dec 2014	10-K	10 Mar 2017	2016	FY
2013	17,760,000	+17,742,369		01 Jan 2013	31 Dec 2013	10-K	18 Mar 2016	2015	FY
2012	17,631^*	+34		01 Jan 2012	31 Dec 2012	10-K	27 Feb 2015	2014	FY
2011	17,597^*	-17,349,403		01 Jan 2011	31 Dec 2011	10-K/A	08 May 2014	2013	FY
2010	17,367,000			01 Jan 2010	31 Dec 2010	10-K	01 Apr 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.